Finland· FI-REL-REL60475

Lonquex

A lipegfilgrastim product containing lipegfilgrastim, registered in Finland by Teva B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC L03AA14

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLonquexATCL03AA14REGISTER NO.FI-REL-REL60475PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Lipegfilgrastim is registered in 12 of 19 countries.

Countries holding a registration under ATC L03AA14 (lipegfilgrastim), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Lipegfilgrastim · ATC L03AA14

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Lipegfilgrastim
Manufacturer
Teva B.V.
Country
Finland (FI)
ATC code
L03AA14
ATC class
Lipegfilgrastim
Defined daily dose
0.3 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lipegfilgrastim in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lipegfilgrastim products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Lonquex
  • Iceland · Lonquex
  • Liechtenstein · Lonquex
  • Norway · Lonquex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8ccb2d7-54cb-451a-b1cf-7561ba95247b
GET /v1/drugs/f8ccb2d7-54cb-451a-b1cf-7561ba95247b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.3",
  "form": "injektioneste, liuos",
  "route": "Ihon alle",
  "ddd_unit": "mg",
  "strength": "6 mg/0.6 ml",
  "atc_label": "lipegfilgrastiimi",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/13/856/004-005",
  "fimea_rel_id": "REL60475",
  "authorised_at": "2022-07-22"
}

See everything about lipegfilgrastim.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.